Article Text

Download PDFPDF

LP-161 Tjalma syndrome (Pseudo-Pseudo Meigs Syndrome): polyserositis with increased CA-125 in patients with systemic lupus erythematosus
  1. Dinar Faricy Yaddin1 and
  2. Laniyati Hamijoyo1,2
  1. 1Department of Internal Medicine, Division of Rheumatology, Faculty of Medicine, Padjadjaran University/RSHS, Bandung, Indonesia
  2. 2Department of Internal Medicine, Lupus Study Group, Study Center of Immunology, Faculty of Medicine, Padjadjaran University, Indonesia


Description Tjalma Syndrome (Pseudo-Pseudo Meigs Syndrome) is a rare clinical condition that can occur in patients with systemic lupus erythematosus (SLE). This syndrome is characterized by massive ascites, pleural effusions and increased CA-125 levels without related to benign or malignant tumors. Tjalma Syndrome is a rare condition reported in the literature and currently there are only 14 reports of this condition.

A 31-year-old woman had a major complaint of massive ascites for 3 months. She had fatigue, hair loss, joints pain, shortness of breath and lower legs edema. Her laboratory revealed positive ANA 1: 10.000, speckled patterns, lymphopenia, proteinuria with urine protein creatinine ratio of 1.773 mg/gr, and she fulfilled the SLE classification criteria based on ACR/EULAR 2019 with mucocutaneous, musculoskeletal, renal involvement and serositis. Analysis of the ascites fluid and pleural effusion showed the exudate and negative results for tuberculosis nor malignant cells. Her CA-125 was markly increased, with no benign or malignant tumors found on either imaging or anatomic pathology examination. Based on these findings, the patient was diagnosed as SLE and Tjalma Syndrome. She was given methylprednisolone pulse dose 500 mg for 3 consecutive days, followed by oral methylprednisolone 0.8 mg/kg daily, mycophenolic acid 720 mg twice daily, hydroxychloroquine 200 mg/d, ramipril 5 mg/d, furosemide 40 mg/d, calcium carbonate 500 mg twice/d and therapeutic ascites punctuation. Patient was discharge in better condition.

Conclusions Tjalma Syndrome is a rare clinical condition, but can be revealed as main presentation of SLE. This case report shows that Tjalma Syndrome could be one of the differential diagnosis of patients with ascites, pleural effusions, and increased CA-125 levels in SLE patients. Possible malignancy should be ruled out, and Tjalma syndrome should be considered so that the patient with this condition can get the proper management and avoid unnecessary surgical examination.

  • Tjalma Syndrome
  • Polyserositis
  • CA-125

This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See:

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.